life science News
-
Clinical trials explained
On November 4, Jeanette Prangsgaard held a presentation at the ‘Clinical Trials’ even, organised by Synapse – Life Science Connect Aalborg. Jeanette spoke about clinical trials, what they entail, and what her role is in the process of the development of our prophylactic HPV vaccine, to pique the interest of students and recent graduates. The aim of the event is to bridge the ...
-
2018 Ready to Rocket Winner
Honored to be recognized by “Ready to Rocket” as one of the 10 featured Life Sciences companies to experience accelerated growth. We’re excited for the future! About Ready to Rocket: Ready to Rocket is a unique business recognition list that profiles technology companies with the greatest potential for growth. Each year, based on analysis of trends, Rocket Builders identifies ...
-
Public Awareness Campaign Aims to `SLAP` Down the Mosquito Threat through Education and Prevention Tips
Schaumburg, 111., June 21, 2017 - With summer weather and outdoor activities in full swing around the United States, the "SLAP" mosquito awareness campaign is taking to the streets of Chicago. Houston and Fort Lauderdale to emphasize the importance of controlling mosquitoes and preventing the diseases they spread. Beginning this week, a brightly colored mobile billboard will travel through each ...
-
Hybrisan Take Part in MediWales Seminar
In September, our Technical Director Dr Chris Mortimer addressed an audience of medical and life sciences professionals as he took part in a webinar hosted the Life Sciences network MediWales. Chris talked about the Hybrisan product, how it is alcohol-free, and what it makes it unique. He also talks about our relationship with Gwalia Healthcare, who supply the Hybrisan product. Click below to ...
-
Replicel Announces Extension to Private Placement
Replicel Life Sciences Inc. (the “Company” or “Replicel”) announces that the TSX Venture Exchange (the “Exchange”) has granted a thirty (30) day extension to the Company for completion of its non-brokered private placement (the “Offering”), previously announced in its News Release of March 21, 2022. The terms of the Private Placement provide for ...
-
RepliCel Announces Non-brokered Private Placement
RepliCel Life Sciences Inc. (OTCPK: REPCF) (TSXV: RP) (FRA:P6P2) (“RepliCel” or the “Company”), a company developing novel, next-generation injection technologies as well as regenerative medicine products in aesthetics and orthopedics, is pleased to announce a non-brokered private placement financing (the “Offering”) of up to 8,333,333 units (each, a ...
-
RepliCel Terminates License Agreement with Shiseido
RepliCel Life Sciences Inc. (OTCPK: REPCF) (TSXV: RP) (FRA:P6P2) (“RepliCel” or the “Company”), a company developing next-generation technologies in aesthetics and orthopedics, announced today that the dispute between Shiseido and RepliCel has led to the Company electing to terminate the license agreement with Shiseido. The Company’s decision is a legal step in its ...
-
Acuitas Therapeutics to Receive Life Sciences BC Awards
Dr. Thomas Madden, President & CEO of Acuitas Therapeutics, is pleased to announce that Acuitas has been recognized as Company of the Year by Life Sciences BC (LSBC). Acuitas Therapeutics’ co-founder, Dr. Pieter Cullis, is this year’s recipient of LSBC’s Global Impact Award. “We are honoured to have Acuitas Therapeutics named as Company of the Year by Life Sciences ...
-
JSR Appoints Veteran Biotech and CDMO Leader Mark W. Womack to Lead KBI Biopharma and Selexis SA
JSR Life Sciences, LLC (JSR) today announced that Mark W. Womack will serve as the Chief Executive Officer of two of its affiliate companies: KBI Biopharma, a leading global CDMO specializing in drug development and biologics manufacturing, and Selexis SA, an industry-leading cell line development provider. Womack will be responsible for the strategic vision, continued growth, and organizational ...
-
RepliCel Closed Final Tranche of Strategic Investment Commitment
RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSXV: RP) (FRA:P6P2) (“RepliCel” or the “Company”), a company developing next-generation technologies in aesthetics and orthopedics, is pleased to announce that it has closed the final tranche of the investment by MainPointe Pharmaceuticals (“MainPointe”) as outlined in the share purchase agreement signed by the ...
-
Meet Pluto at Bio-IT World 2022!
The Pluto team is attending our first Bio-IT World Conference & Expo in Boston May 3-5, 2022! We’re looking forward to learning about all of the impactful research the attendees are doing, and sharing how Pluto is accelerating R&D for life sciences organizations of all sizes. It’s been so exciting to see the progress over the past 6 months I’ve worked at Pluto, and I ...
-
Gérard Ber appointed as additional Board Member
CUTISS AG, an innovative Swiss Life Science Company aiming to provide patients that suffer from large and deep skin defects with an automatically produced, personalized skin tissue therapy, denovoSkin™, today announced it has further enhanced its Board of Directors with Gerard Ber as newly elected, additional and independent Member of the Board. At the recent Annual Shareholder Meeting ...
By CUTISS AG
-
cion Hosts Symposium: Medical Devices in the Emerging Chinese Market
November 21, 2011 – Waltham, Massachusetts. Scion Medical Technologies co-hosted the symposium, “Medical Devices in the Emerging Chinese Market”. Scion and its co-host, CMC Group, the investment arm of China Medical City, a government backed life sciences economic zone in Taizhou, China, brought together a panel of leading medical device industry experts from the U.S. and China ...
-
Mosquito-Awareness.com Launched as Educational and Disease Prevention Resource for Mosquito Control Professionals
Schaumburg, III., April 11,2016 - Central Life Sciences, whose founders invented insect growth regulator (IGR) technology more than 35 years ago, today announced the launch of w^^w.mosquito-awareness.com. a site created to raise visibility of the potentially deadly diseases mosquitoes can spread, and educate visitors about preventing exposure and transmission. As part of an overall public ...
-
Zeto has won the prestigious 2021 UCSF Health Award in Hospital Diagnostics
Zeto was among over 1,200 global digital health and life sciences companies competing across 16 categories of the prestigious awards program produced by the UCSF Health Hub. UCSF Health Hub is a 501c3 non-profit supported and funded by Silicon Valley’s top health-related venture capital firms in a unique affiliation with UCSF. To see video, please click ...
By Zeto, Inc.
-
EECO2 delivering over £10 million in global energy savings to Pharmaceutical & Life Sciences sector
Leading Energy Efficiency Consultancy EECO2 has delivered over £10 million in global energy savings to the pharmaceutical & life science sector. The energy savings are displayed on their website at www.eeco2.co.uk. The savings delivered to date amount to an astounding 252,217,127kWh and 91,564 Co2 tonnes. EECO2 have firmly established their position as a leading energy consultancy ...
-
Natalie Dakers: Chair of Augurex’s Board of Directors Receives 2019 Milton Wong Award
Ms. Dakers began her career in Life Sciences at the University of British Columbia, managing technology transfer for the University Industry Liaison Office (UILO) where she was involved in the creation and spin-off of more than a dozen start-up high-tech and biotech companies. She then went on to co-found NeuroMed Technologies Inc., a private biotechnology company developing drugs for pain, ...
-
Amerigo Scientific Adds Viral Transport Medium CDC Protocol to Its Distribution List
Amerigo Scientific, a distributor focused on providing critical products and services to biomedical and life science communities, recently cooperates with Life Science Group to distribute the Viral Transport Medium CDC Protocol. This item is designed to aid researchers in their efforts to study the latest virus strains and improve their understanding of the physiology and life cycle of viruses. ...
-
Agilent Technologies to present at jefferies global healthcare conference and goldman sachs global healthcare conference
Agilent Technologies Inc. (NYSE: A) today announced the following webcasts for the investment community: Jefferies 2011 Global Healthcare Conference Wednesday, June 8, 9 a.m. (ET) Grand Hyatt, New York, N.Y. Mike McMullen, President, Chemical Analysis Group Goldman Sachs 32nd Annual Global Healthcare Conference Wednesday, June 8, 8:40 a.m. (PT) Terranea Resort, Rancho Palos Verdes, Calif. ...
-
Showcase
10 Years of Peer-Reviewed Studies Predicting and Informing the Prognosis Profile of Autoimmune Patients
Recent journal publications are fortifying the clinically important role of the 14-3-3η blood test along the whole continuum of RA and autoimmune patient care. From RA meta-analysis data through to 14-3-3η expression in juvenile idiopathic arthritis and secondary Sjögren’s syndrome in Lupus, the importance of this protein across a spectrum of autoimmune conditions is ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you